stockrowAgenus Inc. (AGEN) vs X4 Pharmaceuticals, Inc. (XFOR)
- Agenus Inc. AGEN 7.13 +10.71%
- X4 Pharmaceuticals, Inc. XFOR 3.15 +2.61%
Agenus Inc. and X4 Pharmaceuticals, Inc. are both Biotechnology companies. Agenus Inc. and X4 Pharmaceuticals, Inc. are of similar size ($304.4M and $290.8M). X4 Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Agenus Inc. trades at 10.7×. Agenus Inc. grew revenue faster over the last twelve months: 25.4% against −50.1%. Agenus Inc. has the higher net margin (22.0% vs −474.7%) and the higher return on invested capital (0.00% vs −178.2%). Across the 16 metrics below, Agenus Inc. leads on 14 and X4 Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | AGEN | XFOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 81.77% | 68.51% |
| Operating margin | 38.94% | (473.95%) | 0.00% |
| Net margin | 21.99% | (474.74%) | 0.00% |
| Free cash flow margin | (77.54%) | (478.16%) | 0.00% |
| Return on equity | (14.99%) | (80.32%) | (51.96%) |
| Return on assets | 12.29% | (40.73%) | (46.06%) |
| Return on invested capital | 0.00% | (178.23%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack